Benlysta 400 TR

$1,199.00

Benlysta is specifically indicated for the treatment and management of the symptoms of lupus. This substance is a human monoclonal antibody.

Quantity Price
1 - 5 $1,199.00
6 - 10 $1,189.00
11 - 20 $1,184.00
21+ $1,179.00
SKU: 88878 Category:

Description

Benlysta is an FDA-approved drug that is specifically indicated to treat and manage the symptoms of lupus. This substance is a human monoclonal antibody that is directed against the human BLyS protein so as to affect the survivability of B-cells, which are immune cells that are involved in the production of autoantibodies. Benlysta inhibits the binding of B Lymphocyte Stimulator (BLyS), a protein essential for B-cell survival, to its receptor on B-cells. By doing so, the numbers of B-cell numbers decline, and related disease activity is subsequently lowered.